PIEDMONT INVESTMENT ADVISORS INC - PROTEOSTASIS THERAPEUTICS IN ownership

PROTEOSTASIS THERAPEUTICS IN's ticker is PTI and the CUSIP is 74373B109. A total of 57 filers reported holding PROTEOSTASIS THERAPEUTICS IN in Q3 2018. The put-call ratio across all filers is 1.26 and the average weighting 0.0%.

Quarter-by-quarter ownership
PIEDMONT INVESTMENT ADVISORS INC ownership history of PROTEOSTASIS THERAPEUTICS IN
ValueSharesWeighting
Q2 2018$1,0004370.00%
Other shareholders
PROTEOSTASIS THERAPEUTICS IN shareholders Q3 2018
NameSharesValueWeighting ↓
HARBOURVEST PARTNERS LLC 440,627$2,093,0002.25%
NEA Management Company, LLC 5,556,778$26,395,0001.17%
Endurant Capital Management LP 472,012$2,242,0000.84%
DAFNA Capital Management LLC 267,100$1,269,0000.62%
RTW INVESTMENTS, LP 1,104,940$5,248,0000.50%
DOHENY ASSET MANAGEMENT /CA 69,625$331,0000.17%
BAILARD, INC. 520,100$2,470,0000.16%
Bain Capital Public Equity Management, LLC 399,947$1,900,0000.14%
Rock Springs Capital Management LP 675,000$3,206,0000.14%
Hillhouse Capital Management 865,923$4,113,0000.07%
View complete list of PROTEOSTASIS THERAPEUTICS IN shareholders